Exact Sciences (NASDAQ:EXAS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Exact Sciences (EXAS) operate in?

Exact Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Exact Sciences Stock (NASDAQ: EXAS) stock price, news, charts, stock research, profile.

Open	$57.86
Close	$57.48
Volume / Avg.	951.13K / 2.37M
Day Range	$57.29 - $58.66
52 Wk Range	40.62 - 79.62
Market Cap	$10.64B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	6.11%
Days to Cover	5.82

Recent News

Rivian Automotive, Rocket Lab And Moderna Are Among Top 10 Large-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?

Top performers last week: RIVN, RKLB, SRPT, EXAS, ESTC, ULTA, MRNA, RL, CPRT, SNAP. Any in your portfolio? Citigroup raises price target on ULTA and SNAP.

Lekha Gupta

Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED)

Centers for Medicare & Medicaid Services finalizes 2025 pricing for Exact Sciences' Cologuard Plus, raising Medicare reimbursement by 16% and boosting growth projections for next year.

Vandana Singh

J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$57.86
Close	$57.48
Volume / Avg.	951.13K / 2.37M
Day Range	$57.29 - $58.66
52 Wk Range	40.62 - 79.62
Market Cap	$10.64B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	6.11%
Days to Cover	5.82

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Exact Sciences (EXAS) stock?

You can purchase shares of Exact Sciences (NASDAQ:EXAS) through any online brokerage.

View our list of the best stock brokerages

Who are Exact Sciences (EXAS) competitors?

Other companies in Exact Sciences’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV), Amgen (NASDAQ:AMGN) and United Therapeutics (NASDAQ:UTHR).

What is the forecast, or price target, for Exact Sciences (EXAS) stock?

Exact Sciences has a consensus price target of $75.04.

What is the current price for Exact Sciences (EXAS)?

The stock price for Exact Sciences (NASDAQ: EXAS) is $57.48 last updated December 26, 2024 at 4:00 PM EST.

Does Exact Sciences (EXAS) pay a dividend?

There are no upcoming dividends for Exact Sciences.

When is Exact Sciences (NASDAQ:EXAS) reporting earnings?

Exact Sciences’s Q4 earnings are confirmed for Wednesday, February 19, 2025.

Is Exact Sciences (EXAS) going to split?

There is no upcoming split for Exact Sciences.

What sector and industry does Exact Sciences (EXAS) operate in?

Exact Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Exact Sciences

Exact Sciences (EXAS) Forecast